Evaluation of Safety and Efficacy of Two Ticagrelor-based De-escalation Antiplatelet Strategies in Acute Coronary Syndrome
A phase 3 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 4500 participants.
Also called NCT04718025
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 4,500 participants
- Registry
-
NCT04718025
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Poland
- Registry status
- Unknown status
Technical summary
Registry record NCT04718025. Randomized; quadruple masking; primary purpose treatment. Start 2022-02-07 (actual); primary completion 2024-06-30 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Evaluation of Safety and Efficacy of Two Ticagrelor-based De-escalation Antiplatelet Strategies in Acute Coronary Syndrome
- Acronym
- ELECTRA-SIRIO
- Condition
- STEMI
- Condition
- NSTEMI
- Condition
- Unstable Angina
- Intervention (Drug)
- Ticagrelor 90mg
- Intervention (Drug)
- Ticagrelor 60mg
- Intervention (Drug)
- Aspirin
- Lead sponsor
- Collegium Medicum w Bydgoszczy
- Collaborator
- Medical Research Agency, Poland
Record details
- Record id
cardio:ct-nct04718025- Content hash
15a9c395ae6d9ae11517b0c0d316fa5628ec11412c23d39cb853525232fbfefb